What is Eikon Therapeutics, Inc. 's total current liabilities?

Eikon Therapeutics, Inc. (EIKN) reported total current liabilities of $45.06M in Q1 2026.

What does total current liabilities mean?

The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

MYR GroupMYRG

$827.68M+12.0%

BeldenBDC

$613.63M+4.3%

Cabot CorporationCBT

$1.07B+30.6%

UnifirstUNF

$290.41M+4.6%

HES

Hess MidstreamHESM

$181.2M-2.6%

Alkami Technology, Inc.ALKT

$73.76M+16.6%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's total current liabilities?: Eikon Therapeutics, Inc. (EIKN) reported total current liabilities of $45.06M in Q1 2026.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.